CareDx, Inc (CDNA) vs Dyne Therapeutics, Inc. (DYN)
A side-by-side comparison of CareDx, Inc and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$69.13HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
DYN
Dyne Therapeutics, Inc.
$15.16HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CDNA vs DYN
growth of $100 · dividends reinvested · last 6yCDNA +107.0% (+12.9%/yr)DYN -35.4% (-7.0%/yr)CDNA compounded faster over this window
CDNA DYN
CDNA vs DYN: by the numbers
- •CDNA is the larger company ($3.58B vs $2.83B market cap).
- •CDNA is profitable (24.23% net margin) while DYN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CDNA | DYN |
|---|---|---|
| P/E ratio | 33.37 | N/A |
| Forward P/E | 57.71 | N/A |
| P/S ratio | 7.81 | N/A |
| P/B ratio | 8.40 | 4.03 |
| EV / EBITDA | 207.08 | N/A |
| FCF yield | 2.38% | N/A |
Profitability
| Metric | CDNA | DYN |
|---|---|---|
| Gross margin | 70.58% | 0.00% |
| Operating margin | -0.92% | 0.00% |
| Net margin | 24.23% | 0.00% |
| ROE | 26.08% | -73.97% |
| ROIC | -0.93% | -58.28% |
Growth (annualized)
| Metric | CDNA | DYN |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | -0.38% |
Frequently asked
- Is CDNA or DYN more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus DYN at 0.00%.
- How have CDNA and DYN total returns compared?
- Over the past 5 years, CDNA delivered 1.33% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROEDyne Therapeutics ROECareDx operating marginDyne Therapeutics operating marginCareDx revenue growthDyne Therapeutics revenue growthCareDx free cash flowDyne Therapeutics free cash flow
CareDx & Dyne Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.